Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infinity-Swedeheart Study: Registry Based Randomized Clinical Trial (R-RCT) Comparing Long Term Outcomes of the DynamX Bioadaptor to the Resolute Onyx Stent in a More-comer PCI Patient Population

NCT04562805 is registered in ClinicalTrials.gov with Elixir Medical Corporation as lead sponsor.

NCT NCT04562805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04562805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infinity-Swedeheart Study: Registry Based Randomized Clinical Trial (R-RCT) Comparing Long Term Outcomes of the DynamX Bioadaptor to the Resolute Onyx Stent in a More-comer PCI Patient Population
Lead sponsor
Elixir Medical Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2020
Completion date
July 31, 2028
Enrollment
2,400 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ischemic heart disease